Eric J Duncavage

Washington University

$2,152,736

Attributed

$4,305,472

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY2017–25

$2M$1.5M$1M$500K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,305,472 · 5

By mechanism

R33$2,270,843 · 2

U01$1,384,429 · 1

UH3$388,750 · 1

UH2$261,450 · 1

Top collaborators

David H Spencer8 shared
Matthew J Walter3 shared

Most similar at Washington University

Same institution · by research overlap

Ellen Li$7,845,211
Elaine R Mardis$11,835,945
David H Spencer$4,158,658
Jacqueline E. Payton$4,312,454
Ali Hassan Ellebedy$14,119,121

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsEvaluationMutationPerformanceTumorWhole GenomeFutureInsertion/Deletion MutationGenome SequencingSomatic MutationGenomicsCancer PatientTechnologyDna SequencingResearch Clinical TestingSamplingDiagnosisLaboratoriesClinical TrialsGenesSuccessDna Sequence AlterationChromosomal RearrangementExperimental Study